"I won't hold my breath, because most of my patients do relapse at some point, but I was really excited about this curve when ...

The Cocoon® (from Lonza) is a functionally closed, sterile, efficient manufacturing platform, which combined with our ...

A clinical trial using engineered immune cells to hunt cancer cells has reported impressive results for solid tumours, a type ...

A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent ...

A LIVING cancer drug has been proven to work against solid tumours for the first time. Immune-boosting CAR-T therapy removes ...

Cell and gene therapy (CGT) represents the pinnacle of biomedical innovation, offering unprecedented potential to treat, ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

During a live event, Konstantinos Sdrimas, MD, asked participants what community oncologists should consider when referring ...

This research roundup discusses researchers’ attempts to find a treatment for a “brain fog” that comes with CAR T-Cell ...

Researchers from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinikum Erlangen have succeeded in treating a patient with a ...

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing brain ...

Researchers are developing an in vivo approach to engineer cancer-fighting immune cells, potentially making the powerful CAR ...